Pharmarise Holdings (TSE:2796) EPS (Basic): 円10.01 (TTM As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2796 Pharmarise Holdings Corp TSE:2796
50 GF Score
Price 円491.00
GF Value 円608.07
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Pharmarise Holdings EPS (Basic)?

Pharmarise Holdings TSE:2796 -0.61% 50 EPS (Basic) is 円10.01 as of May. 2026. GuruFocus rates TSE:2796 with a GF Score™ of 50/100 and a GF Value™ of 円608.07 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Pharmarise Holdings's basic earnings per share (Basic EPS) for the six months ended in May. 2026 was 円0.26. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in May. 2026 was 円10.01.

Pharmarise Holdings's EPS (Diluted) for the six months ended in May. 2026 was 円0.26. Its EPS (Diluted) for the trailing twelve months (TTM) ended in May. 2026 was 円9.63.

Pharmarise Holdings's EPS without NRI for the six months ended in May. 2026 was 円0.26. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in May. 2026 was 7.04.

During the past 3 years, the average EPS without NRI Growth Rate was -42.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Pharmarise Holdings's highest 3-Year average EPS without NRI Growth Rate was 67.50% per year. The lowest was -44.90% per year. And the median was -9.10% per year.

Pharmarise Holdings  (TSE:2796) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Pharmarise Holdings EPS (Basic) Related Terms

Pharmarise Holdings EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Pharmarise Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmarise Holdings EPS (Basic) Chart

Pharmarise Holdings Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.99 35.45 -33.41 -32.48 10.01

Pharmarise Holdings Semi-Annual Data
Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25 May26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.70 -10.09 -22.39 9.75 0.26
TSE:2796
50GF Score
Pharmarise Holdings Corp TSE:2796
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmarise Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Pharmarise Holdings's Basic EPS for the fiscal year that ended in May. 2026 is calculated as

Basic EPS (A: May. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(114-0)/11.322
=10.07

Pharmarise Holdings's Basic EPS for the quarter that ended in May. 2026 is calculated as

Basic EPS (Q: May. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3-0)/11.235
=0.27

EPS (Basic) for the trailing twelve months (TTM) ended in May. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円10.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of 円10.01 mean?
Pharmarise Holdings (TSE:2796) has a EPS (Basic) of 円10.01 as of May. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Pharmarise Holdings and its competitors.
Is Pharmarise Holdings' EPS (Basic) too high?
Pharmarise Holdings' current EPS (Basic) is 円10.01. Overall, Pharmarise Holdings has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharmarise Holdings' EPS (Basic) compare to competitors?
Pharmarise Holdings' EPS (Basic) of 円10.01 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Pharmarise Holdings and its competitors. Pharmarise Holdings's current EPS (Basic) is 円10.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmarise Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pharmarise Holdings (TSE:2796) is currently considered Modestly Undervalued. The stock's GF Value™ is 円608.07, compared to a current price of 円491.00 — trading 19.3% below its estimated fair value. The current EPS (Basic) is 円10.01. Pharmarise Holdings' overall GF Score™ is 50/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Pharmarise Holdings (TSE:2796), the current EPS (Basic) is 円10.01 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmarise Holdings (TSE:2796) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmarise Holdings stock appears to be undervalued. The current stock price of 円491.00 is trading 19.3% below its estimated GF Value™ of 円608.07. GuruFocus considers Pharmarise Holdings to be Modestly Undervalued.

Key valuation signals for TSE:2796:

  • EPS (Basic): 円10.01
  • GF Value™: 円608.07 vs. price of 円491.00 (19.3% below fair value)
  • GF Score™: 50/100 with 10 warning signs

No single metric tells the full story. See the TSE:2796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmarise Holdings Business Description

Address 8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on the prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.
50GF Score

Get the complete analysis for TSE:2796

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円491.00
Price
円608.07
GF Value